CBD reduced brain inflammation and improved memory in diabetic rats with impaired brain blood flow | Research

The takeaway

CBD treatment improved memory and reduced brain inflammation markers in middle-aged diabetic rats subjected to chronic cerebral hypoperfusion, though it did not affect neuroplasticity markers.

Researchers studying CBD neuroprotection, diabetes-related cognitive decline, and cerebrovascular disease.

CBD reduced four inflammation markers in the hippocampus

What the researchers found

Diabetes worsened cognitive deficits from chronic cerebral hypoperfusion in middle-aged rats. CBD (10 mg/kg daily for 30 days) improved memory performance and reduced hippocampal levels of multiple inflammation markers (iNOS, Iba1, GFAP, arginase 1). CBD also attenuated the BDNF decrease caused by hypoperfusion. CBD did not affect neuroplasticity markers (GAP-43, synaptophysin) and caused weight loss.

Why it matters

Diabetes and aging together dramatically increase the risk of cognitive decline from reduced brain blood flow. Finding that CBD can protect against this combined insult suggests it targets the inflammatory pathway that worsens the damage.

The numbers in context

CBD dose: 10 mg/kg daily for 30 days. Reduced iNOS, Iba1, GFAP, and arginase 1 in hippocampus. Preserved BDNF levels. Did not affect GAP-43 or synaptophysin. Caused weight loss.

How the study worked

Middle-aged rats (14 months) were made diabetic with streptozotocin, subjected to chronic cerebral hypoperfusion surgery, then treated with CBD 10 mg/kg/day for 30 days. Memory, inflammation markers, and neuroplasticity markers were assessed.

What this study cannot tell us

Animal study using a pharmacological diabetes model. Only one CBD dose tested. The weight loss effect of CBD needs further investigation. Results may not translate directly to humans.

How to read the evidence

Preliminary: single animal study with one dose in a specific disease model.

When this study was published

Published in 2019.

The bigger picture

With diabetes and vascular disease both increasing globally, the intersection of these conditions with cognitive decline is a growing public health concern. CBD's anti-inflammatory properties may address a key mechanism in this process.

Questions still open

Would CBD be effective in human patients with diabetes and cerebrovascular disease? Is the memory improvement driven entirely by inflammation reduction? Could combining CBD with standard diabetes treatment provide synergistic protection?

Common questions

What is chronic cerebral hypoperfusion?

It refers to chronically reduced blood flow to the brain, which can occur with aging, diabetes, and cardiovascular disease. Over time, it leads to cognitive decline and increases dementia risk.

Why did CBD cause weight loss?

CBD-induced weight loss has been observed in other studies and may relate to its effects on appetite regulation, fat metabolism, or energy expenditure. This effect was seen in both sham and hypoperfusion groups.

Read the original research

Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.

Neurotoxicity research, 35(2), 463-474

View on PubMed ↗Publisher’s paper ↗

Citation

Santiago, Amanda Nunes; Mori, Marco Aurélio; Guimarães, Francisco Silveira; Milani, Humberto; Weffort de Oliveira, Rúbia Maria. (2019). Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.. Neurotoxicity research, 35(2), 463-474. https://doi.org/10.1007/s12640-018-9972-5